MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease

por Decourt, Boris, Wilson, Jeffrey, Ritter, Aaron, Dardis, Christopher, DiFilippo, Frank P, Zhuang, Xiaowei, Cordes, Dietmar, Lee, Garam, Fulkerson, Nadia D, St Rose, Tessa, Hartley, Katurah, Sabbagh, Marwan N
Publicado 2020